Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hu Xie

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 6, 2012
Efficiency and risk factors for CMV transmission in seronegative hematopoietic stem cell recipientsSteven A Pergam, Hu Xie, Ravinder Sandhu, et al.
The Journal of Infectious Diseases|September 22, 2019
Predictive Value of Respiratory Viral Detection in the Upper Respiratory Tract for Infection of the Lower Respiratory Tract With Hematopoietic Stem Cell TransplantationJim Boonyaratanakornkit, Meghana Vivek, Hu Xie, et al.
World Journal of Clinical Oncology|May 1, 2024
Molecular targets and mechanisms of different aberrant alternative splicing in metastatic liver cancerDe-Yi Geng, Qing-Shan Chen, Wan-Xian Chen, et al.
Open Forum Infectious Diseases|January 26, 2026
Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Clinical and Humoral Risk Factors for InfectionSara Pernikoff, Annelie Clurman, Melanie Rötepohl, et al.
The Journal of Infectious Diseases|August 26, 2017
Prolonged Shedding of Human Coronavirus in Hematopoietic Cell Transplant Recipients: Risk Factors and Viral Genome EvolutionChikara Ogimi, Alexander L Greninger, Alpana A Waghmare, et al.
The Journal of Infectious Diseases|February 10, 2017
Cytomegalovirus (CMV) DNA Quantitation in Bronchoalveolar Lavage Fluid From Hematopoietic Stem Cell Transplant Recipients With CMV PneumoniaMichael Boeckh, Terry Stevens-Ayers, Giovanna Travi, et al.
Annals of Internal Medicine|January 7, 2015
Valganciclovir for the prevention of complications of late cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a randomized trialMichael Boeckh, W Garrett Nichols, Roy F Chemaly, et al.
Contemporary Clinical Trials Communications|February 11, 2017
A MULTICENTER, LONGITUDINAL, INTERVENTIONAL, DOUBLE BLIND RANDOMIZED CLINICAL TRIAL IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS RESIDING IN REMOTE AREAS: LESSONS LEARNED FROM THE LATE CYTOMEGALOVIRUS PREVENTION TRIALLouise E Kimball, Terry Stevens-Ayers, Margaret L Green, et al.
Open Forum Infectious Diseases|November 3, 2025
Cytomegalovirus Viral Load Continues to Predict Poor Outcomes in Adults and Children Despite Improved Hematopoietic Cell Transplantation SuccessAlicja Sadowska-Klasa, Hu Xie, Danniel Zamora, et al.
Haematologica|February 11, 2017
Human rhinovirus detection in the lower respiratory tract of hematopoietic cell transplant recipients: association with mortalitySachiko Seo, Alpana Waghmare, Emily M Scott, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 6, 2012
Efficiency and risk factors for CMV transmission in seronegative hematopoietic stem cell recipientsSteven A Pergam, Hu Xie, Ravinder Sandhu, et al.
The Journal of Infectious Diseases|September 22, 2019
Predictive Value of Respiratory Viral Detection in the Upper Respiratory Tract for Infection of the Lower Respiratory Tract With Hematopoietic Stem Cell TransplantationJim Boonyaratanakornkit, Meghana Vivek, Hu Xie, et al.
World Journal of Clinical Oncology|May 1, 2024
Molecular targets and mechanisms of different aberrant alternative splicing in metastatic liver cancerDe-Yi Geng, Qing-Shan Chen, Wan-Xian Chen, et al.
Open Forum Infectious Diseases|January 26, 2026
Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Clinical and Humoral Risk Factors for InfectionSara Pernikoff, Annelie Clurman, Melanie Rötepohl, et al.
The Journal of Infectious Diseases|August 26, 2017
Prolonged Shedding of Human Coronavirus in Hematopoietic Cell Transplant Recipients: Risk Factors and Viral Genome EvolutionChikara Ogimi, Alexander L Greninger, Alpana A Waghmare, et al.
The Journal of Infectious Diseases|February 10, 2017
Cytomegalovirus (CMV) DNA Quantitation in Bronchoalveolar Lavage Fluid From Hematopoietic Stem Cell Transplant Recipients With CMV PneumoniaMichael Boeckh, Terry Stevens-Ayers, Giovanna Travi, et al.
Annals of Internal Medicine|January 7, 2015
Valganciclovir for the prevention of complications of late cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a randomized trialMichael Boeckh, W Garrett Nichols, Roy F Chemaly, et al.
Contemporary Clinical Trials Communications|February 11, 2017
A MULTICENTER, LONGITUDINAL, INTERVENTIONAL, DOUBLE BLIND RANDOMIZED CLINICAL TRIAL IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS RESIDING IN REMOTE AREAS: LESSONS LEARNED FROM THE LATE CYTOMEGALOVIRUS PREVENTION TRIALLouise E Kimball, Terry Stevens-Ayers, Margaret L Green, et al.
Open Forum Infectious Diseases|November 3, 2025
Cytomegalovirus Viral Load Continues to Predict Poor Outcomes in Adults and Children Despite Improved Hematopoietic Cell Transplantation SuccessAlicja Sadowska-Klasa, Hu Xie, Danniel Zamora, et al.
Haematologica|February 11, 2017
Human rhinovirus detection in the lower respiratory tract of hematopoietic cell transplant recipients: association with mortalitySachiko Seo, Alpana Waghmare, Emily M Scott, et al.
Pageof 12